Nisa Investment Advisors
ALT icon

Nisa Investment Advisors’s Altimmune ALT Stock Holding History

Nisa Investment Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72K Buy
895
+800
+842% +$2.39K ﹤0.01% 2712
2026
Q1 		$293 Hold
95
– – ﹤0.01% 2932
2025
Q4 		$343 Hold
95
– – ﹤0.01% 2867
2025
Q3 		$358 Sell
95
-281
-75% -$1.08K ﹤0.01% 2896
2025
Q2 		$1.46K Buy
376
+9
+2% +$49 ﹤0.01% 2669
2025
Q1 		$1.83K Sell
367
-78
-18% -$494 ﹤0.01% 2491
2024
Q4 		$3.21K Buy
445
+169
+61% +$1.29K ﹤0.01% 2372
2024
Q3 		$1.7K Buy
276
+99
+56% +$671 ﹤0.01% 2440
2024
Q2 		$1.18K Buy
177
+35
+25% +$258 ﹤0.01% 2482
2024
Q1 		$1.45K Buy
142
+29
+26% +$295 ﹤0.01% 2290
2023
Q4 		$1.27K Hold
113
– – ﹤0.01% 2223
2023
Q3 		$294 Buy
+113
New +$324 ﹤0.01% 2615

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's ALT Position: Q2 2026 in Review

Nisa Investment Advisors increased its Altimmune (ALT) stake by 842% in Q2 2026, buying an estimated $2.39K and bringing the position to 895 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

Nisa Investment Advisors first reported a position in ALT in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.21K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Nisa Investment Advisors held 895 shares of Altimmune worth $2.72K as of Q2 2026.
  • Nisa Investment Advisors bought 800 Altimmune shares in Q2 2026, an estimated $2.39K.
  • Altimmune made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2712 holding.
  • Nisa Investment Advisors first reported a position in Altimmune in Q3 2023 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Altimmune position peaked at $3.21K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.